Back to the search results

Fachklinik Hornheide

Dorbaumstraße 300
48157 Münster

Phone: 0251-32870
Fax: 0251-3287-100
Mail: ed.ediehnroh-kinilkhcaf@tsop

https://www.fachklinik-hornheide.de

Basic information

Number of beds: 140
Number of specialist departments: 5

Number of inpatient cases: 6.345
Number of outpatient cases: 45.433

Hospital owners: Fachklinik Hornheide e. V.
Type of provider: freigemeinnützig

Specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of the minimum quantity agreement

Minimum quantities forecast

Surgical treatment of breast cancer (mamma surgery)

Overall result forecast presentation:	no
Quantity performed reporting year:	0
Quantity forecast year:	0
Examination by state associations?	no
Exemption?	no
Result of the examination by the federal state authorities?	no
Transitional arrangement?	no

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ28	Guideline on quality assurance measures for liposuction procedures for stage III lipedema (QS-RL Liposuction)

Compliance with staffing requirements

Clarifying chat completed: no
Clarifying chat not completed: no
No participation in clarifying chat: no
Notification of non-fulfilment of nursing care not made: no

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
27	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
18	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
9	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

General information

Protection concept against (sexual) violence against children and young people

Advice on prevention and intervention in cases of violence and abuse

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

Is a protection concept in place? Yes
Measures
- Prevention
  
  Information gathering on the topic
  
  Education
- Review
  Recommendations for dealing with/processing cases that have occurred
  Note on the measure
  Im Intranet der Klinik gibt es eine eigene Seite zum Thema Gewaltprävention mit Informationen für Ärzte und medizinisches Personal
  Hier sind verschiedene Informationen zu finden:
  Dokumentationsbogen häusliche Gewalt
  Kontaktdaten der lokalen Opferschutzbeauftragten der Stadt Münster
  Kontaktdaten des Betreuungsgerichts Münster
  Verlinkungen zum Hilfe-Portal Sexueller Missbrauch der Unabhängigen Beauftragten für Fragen des sexuellen Kindermissbrauchs
  
  Last review of the measure
  03.09.2022 16:22:55

Im Intranet der Klinik gibt es eine eigene Seite zum Thema Gewaltprävention mit Informationen für Ärzte und medizinisches Personal Hier sind verschiedene Informationen zu finden: Dokumentationsbogen häusliche Gewalt Kontaktdaten der lokalen Opferschutzbeauftragten der Stadt Münster Kontaktdaten des Betreuungsgerichts Münster Verlinkungen zum Hilfe-Portal Sexueller Missbrauch der Unabhängigen Beauftragten für Fragen des sexuellen Kindermissbrauchs

Commentary on the protection concept

Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.

Drug therapy safety

Steering committee

Drug commission

Electronic support for the admission and anamnesis process (e.g. import of patient master data or medication plans, use of a drug knowledge database, input screen for drugs or anamnesis information)

Provision of one or more electronic drug information systems (e.g. Lauer-Taxe®, ifap klinikCenter®, Gelbe Liste®, Fachinfo-Service®)

Concepts for ensuring the error-free preparation of medications

Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
Zubereitung durch pharmazeutisches Personal
Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen

Electronic support for the supply of patients with drugs

Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)
Sonstige_elektronische_Unterstuetzung

Measures to minimise medication errors

Fallbesprechungen
Maßnahmen zur Vermeidung von Arzneimittelverwechslung
Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)

Measures to ensure seamless drug therapy after discharge

Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
Aushändigung von Patienteninformationen zur Umsetzung von Therapieempfehlungen
Aushändigung des Medikationsplans
bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten

Instruments and measures

The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.

AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.

Special instrument-based equipment

Research & teaching

Job

FL01 - Lectureships / teaching posts at colleges and universities

Explanation

Hautklinik der Universität Köln und Universitätsklinikum Münster (Herr Priv.-Doz. Dr. H.-J. Schulze); Universitätsklinikum Münster (Herr Uni.-Prof. Dr. T. Hirsch, Herr Priv.-Doz. Dr. M. Kückelhaus); Charité- Universitätsmedizin Berlin (Priv.-Doz. Dr. Dr. J. D. Raguse)

FL03 - Student training (clinical traineeship / internship year)

Explanation

Doktoranden Ausbildung Medizinische Fakultät der WWU in MS ; PJ Wahlfach Plastische Chirurgie der WWU Münster

FL04 - Project-related cooperation with colleges and universities

Explanation

Universitätsklinikum Münster;Universitäts-Hautklinik; Sozialmedizin der Universitätsklinik Heidelberg; Plastische Chirurgie und Biophysik, Ruhr-Universität Bochum, Charité-Universitätsmedizin Berlin,Yale Medical School,Harvard Medical, Universität Bremen

FL05 - Participation in multi-centre Phase I/II studies

Explanation

Melanom (GO40558) Merkelzell-Carcinom (EMR100070-003-Studie, ADMEC-Studie), Plattenepithelkarzinom (AliCe), advanced Melanoma, c-SCC, hn-SCC, ACC (Cure-Vac)

FL06 - Participation in multi-centre phase III/IV studies

Explanation

Melanom (COLUMBUS-Studie, Trilogy, COMBI-EU, NivoPass,CA045-001,Starboard, Harmony, PIVOT-12,NivoMela, BERING) Basaliom (NISSO), Merkelzellkarzinom (MCC Trim), Plattenepithelkarzinom (cemiSkin)

FL07 - Initiation and management of uni-centric/multi-centric clinical/scientific studies

Explanation

NOLC Neck Dissektion and outcome in Lipcancer; Lymphknotendissektion der Leiste in d.Chirurgie mal.Hauttumore; Mucograft Langzeit Follow Up; IR-Imaging (Melanom, Basaliom)

FL08 - Editors of scientific journals/textbooks